Hypothalamic–pituitary–prolactin axis

The hypothalamic–pituitary–prolactin axis (HPP axis), also known as the hypothalamic–pituitary–mammary axis or hypothalamic–pituitary–breast axis, is a hypothalamic–pituitary axis which includes the secretion of prolactin (PRL; luteotropin) from the lactotrophs of the pituitary gland into the circulation and the subsequent action of prolactin on tissues such as, particularly, the mammary glands or breasts.[1][2] It is involved in lobuloalveolar maturation of the mammary glands during pregnancy and the induction and maintenance of lactation following parturition.[3] Hormones that control the secretion of prolactin from the pituitary gland include dopamine ("prolactin-inhibiting factor", or "PIF"), estradiol, progesterone, thyrotropin-releasing hormone (TRH), and vasoactive intestinal peptide (VIP).[1][4]

Anatomy

Tuberoinfundibular dopaminergic neurons

The cell bodies of TIDA neurons are located in the arcuate nucleus (infundibular nucleus) of the mediobasal hypothalamus. Their axons project to the external zone of the median eminence, where dopamine is released into the fenestrated capillaries of the primary portal plexus.[5] First identified by Kjell Fuxe in 1963–1964, TIDA neurons are distinguished from nigrostriatal and mesolimbic dopamine populations by their neuroendocrine function.[6] TIDA neurons display intrinsic oscillatory activity and are regulated by gonadal steroids and by prolactin itself.[6]

Lactotrophs

Lactotrophs (also called prolactin cells or mammotrophs) are acidophilic cells of the anterior pituitary that synthesise, store, and secrete prolactin. They develop from the Pit-1 (POU1F1)–dependent lineage, shared with somatotrophs and thyrotrophs.[7] In the normal adult pituitary, lactotrophs constitute approximately 15–25% of anterior pituitary cells; this proportion rises to as high as 50% during pregnancy and lactation owing to estrogen-driven hyperplasia.[8] Lactotrophs are electrically excitable, firing spontaneous action potentials accompanied by calcium transients that sustain continuous exocytosis.[8]

Hypothalamic–hypophyseal portal system

Dopamine released at TIDA terminals enters the long portal veins and is delivered directly to lactotrophs of the anterior pituitary. An additional source of dopamine reaches the anterior lobe from the neurointermediate lobe via short portal vessels.[9] Severing or compressing the pituitary stalk eliminates dopamine delivery and causes prolactin levels to rise sharply, an effect opposite to that seen with every other anterior pituitary hormone.[10]

Regulation of prolactin secretion

Because lactotrophs are constitutively active, prolactin secretion operates through a "release from inhibition" model. Several inhibitory and stimulatory factors modulate the system.

Inhibitory factors

Dopamine

Dopamine is the principal prolactin-inhibiting factor. It acts on D2 receptors (D2R) on the lactotroph membrane. Two D2R isoforms (D2L and D2S) couple to Gi/Go proteins and produce inhibition through multiple time-dependent mechanisms:[11][9]

  • Within seconds, D2R activation opens inwardly rectifying K+ channels, hyperpolarising the membrane and preventing voltage-gated Ca2+ influx, which halts exocytosis.
  • Over minutes to hours, D2R suppresses adenylyl cyclase, lowering cAMP and reducing prolactin gene transcription.
  • Chronically, D2R activates phosphotyrosine phosphatases and modulates ERK/MAPK pathways, inhibiting lactotroph proliferation.

D2R-knockout mice develop lactotroph hyperplasia and frank prolactinomas, confirming the essential anti-proliferative role of dopaminergic signalling.[12]

Somatostatin

Somatostatin acts as a secondary inhibitor of prolactin release, counteracting TRH- and VIP-stimulated secretion.[13]

GnRH-associated peptide

GnRH-associated peptide (GAP), a 56-amino-acid peptide cleaved from the GnRH precursor, was shown in 1985 to inhibit prolactin secretion in rat pituitary cultures at a potency comparable to dopamine.[14] Its physiological significance in vivo remains uncertain, as results have varied across species.[15]

Stimulatory factors

No single dominant prolactin-releasing hormone has been identified, which reinforces the primacy of inhibitory control in this axis.[10]

Thyrotropin-releasing hormone

Thyrotropin-releasing hormone (TRH) is a potent stimulator of prolactin release, acting via phospholipase C to mobilise intracellular calcium and activate protein kinase C.[16] In primary hypothyroidism, elevated TRH stimulates both TSH and prolactin, producing hyperprolactinaemia in approximately 20–40% of hypothyroid patients.[17] However, TRH-knockout mice display normal prolactin levels, indicating that TRH is a modulator rather than an obligate releasing factor.[5]

Vasoactive intestinal peptide

Vasoactive intestinal peptide (VIP) stimulates prolactin release via Gs-coupled receptors, increasing cAMP and activating protein kinase A. VIP-containing neurons are located in the paraventricular nucleus.[5]

Estrogen

Estrogens act through ERα to stimulate prolactin gene transcription directly and to promote lactotroph proliferation. ERα-knockout mice show a 10–20-fold reduction in prolactin mRNA.[18] During pregnancy, rising estrogen levels contribute to the physiological expansion of the lactotroph population.[8]

Other factors

Oxytocin reaches lactotrophs via portal vessels and fulfils the criteria of a prolactin-releasing factor during suckling.[5] Serotonin mediates the nocturnal prolactin surge and suckling-induced prolactin release via 5-HT1A and 5-HT2 receptors.[5] Other reported stimulatory factors include neurotensin, angiotensin II, and galanin.[5] Prolactin-releasing peptide (PrRP), despite its name, does not appear to function as a classical hypophysiotropic releasing factor in vivo.[10]

Short-loop feedback

Prolactin itself provides negative short-loop feedback by acting on long-form prolactin receptors (PRLR) expressed on TIDA neurons, activating the JAK2–STAT5B signalling cascade. This feedback has two temporal components. Within minutes, prolactin switches TIDA neurons from phasic to tonic firing, increasing dopamine release into the portal vasculature.[19] Over 12–16 hours, prolactin increases tyrosine hydroxylase expression and activity, elevating dopamine synthesis.[6] In PRLR-knockout mice, dopaminergic input to the pituitary is markedly reduced despite severe hyperprolactinaemia, confirming that TIDA tone depends on prolactin feedback.[20]

Physiological functions

Lactation

Prolactin is the primary lactogenic hormone. It drives mammary gland development (mammogenesis), milk synthesis (lactogenesis), and maintenance of milk production. PRLR-knockout mice show absent mammary development.[21] During pregnancy, high estrogen and progesterone promote ductal and lobuloalveolar growth but suppress milk secretion; withdrawal of these steroids at parturition permits prolactin-driven lactogenesis. Suckling activates a neuroendocrine reflex: afferent signals from mechanoreceptors inhibit TIDA dopamine release (raising prolactin) while simultaneously triggering oxytocin release for the milk ejection reflex.[5]

Reproduction

Hyperprolactinaemia suppresses the reproductive axis by inhibiting pulsatile GnRH secretion. This operates through kisspeptin neurons: prolactin acts on PRLR expressed on arcuate nucleus KNDy neurons (kisspeptin/neurokinin B/dynorphin), suppressing kisspeptin release and thereby silencing the GnRH pulse generator.[22] This mechanism underlies lactational amenorrhoea: elevated prolactin during breastfeeding physiologically inhibits ovulation.[5]

Immune modulation

Prolactin receptors are expressed on monocytes, macrophages, T cells, B cells, and natural killer cells. Prolactin promotes T-cell activation, stimulates immunoglobulin production, and counterbalances glucocorticoid-induced immunosuppression.[21] However, PRL- and PRLR-deficient mice have surprisingly normal baseline immune profiles, suggesting that prolactin's immunomodulatory role is most important under stress or pathological conditions.[21]

Osmoregulation

In teleost fish, prolactin is the principal freshwater-adapting hormone, preventing ion loss by stimulating ionocyte differentiation in gill epithelia.[23] This is an ancient function of prolactin, conserved across vertebrate evolution. In mammals, the osmoregulatory role is less prominent but includes effects on amniotic fluid regulation and renal sodium handling.[5]

See also

References

  1. ^ a b J. Larry Jameson (22 March 2013). Harrison's Endocrinology, 3E. McGraw Hill Professional. p. 16. ISBN 978-0-07-181487-4.
  2. ^ Puetz, Petra; Bellingrath, Silja; Gierens, Andrea; Hellhammer, Dirk H. (2010). "Neuroendocrine Measures in Behavioral Medicine". Handbook of Behavioral Medicine. pp. 659–670. doi:10.1007/978-0-387-09488-5_43. ISBN 978-0-387-09487-8.
  3. ^ Crowley WR (2015). "Neuroendocrine regulation of lactation and milk production". Compr Physiol. 5 (1): 255–91. doi:10.1002/cphy.c140029. ISBN 9780470650714. PMID 25589271.
  4. ^ Tony M. Plant; Anthony J. Zeleznik (15 November 2014). Knobil and Neill's Physiology of Reproduction. Academic Press. pp. 479–. ISBN 978-0-12-397769-4.
  5. ^ a b c d e f g h i Freeman, ME; Kanyicska, B; Lerant, A; Nagy, G (2000). "Prolactin: structure, function, and regulation of secretion". Physiological Reviews. 80 (4): 1523–1631. doi:10.1152/physrev.2000.80.4.1523. PMID 11015620.
  6. ^ a b c Stagkourakis, S; et al. (2024). "Current review of the function and regulation of tuberoinfundibular dopamine neurons". International Journal of Molecular Sciences. 25 (1): 110. doi:10.3390/ijms25010110. PMC 10778701.
  7. ^ Fauquier, T; et al. (2012). "Cellular and molecular specificity of pituitary gland physiology". Physiological Reviews. 92 (1): 1–38. doi:10.1152/physrev.00003.2011.
  8. ^ a b c Stojilkovic, SS; Tabak, J; Bhatt, DK (2013). "The role of cyclic nucleotides in pituitary lactotroph functions". Frontiers in Endocrinology. doi:10.3389/fendo.2013.00122. PMC 3772395.
  9. ^ a b Ben-Jonathan, N; Hnasko, R (2001). "Dopamine as a prolactin (PRL) inhibitor". Endocrine Reviews. 22 (6): 724–763. doi:10.1210/edrv.22.6.0451. PMID 11739329.
  10. ^ a b c Grattan, DR (2015). "60 years of neuroendocrinology: the hypothalamo-prolactin axis". Journal of Endocrinology. 226 (2): T101–T122. doi:10.1530/JOE-15-0213. PMC 4515538. PMID 26101377.
  11. ^ Fitzgerald, P; Dinan, TG (2008). "Prolactin and dopamine: what is the connection? A review article". Journal of Psychopharmacology. 22 (2 Suppl): 12–19. doi:10.1177/0269881107087148. PMID 18477617.
  12. ^ Saiardi, A; et al. (1997). "Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia". Neuron. 19 (1): 115–126. doi:10.1016/S0896-6273(00)80352-9.
  13. ^ Bjøro, T; et al. (1989). "Somatostatin inhibits prolactin secretion by multiple mechanisms". Endocrinology. 124 (6): 2812–2818. PMID 2906508.
  14. ^ Nikolics, K; Mason, AJ; Szonyi, E; Ramachandran, J; Seeburg, PH (1985). "A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone". Nature. 316 (6028): 511–517. doi:10.1038/316511a0. PMID 2863757.
  15. ^ Clarke, IJ; et al. (1989). "Gonadotropin-releasing hormone associated peptide (GAP) and putative processed GAP peptides do not release luteinizing hormone or follicle-stimulating hormone or inhibit prolactin secretion in the sheep". Neuroendocrinology. 49 (5): 563–565. PMID 3145468.
  16. ^ Bjøro, T; et al. (1990). "The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells". Bioscience Reports. 10 (2): 189–199. doi:10.1007/BF01116578. PMID 2162702.
  17. ^ Melmed, S; Casanueva, FF; Hoffman, AR; Kleinberg, DL; Montori, VM; Schlechte, JA; Wass, JAH (2011). "Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline". Journal of Clinical Endocrinology and Metabolism. 96 (2): 273–288. doi:10.1210/jc.2010-1692. PMID 21296991.
  18. ^ Zaldivar, V; et al. (2008). "Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-α signaling". Endocrinology. PMC 2342177.
  19. ^ Lyons, DJ; et al. (2012). "Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: novel feedback control mechanisms in the lactotrophic axis". Journal of Neuroscience. 32 (23): 8074–8083. doi:10.1523/JNEUROSCI.0129-12.2012. PMID 22674284.
  20. ^ Schuff, KG; et al. (2002). "Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms". Journal of Clinical Investigation. 110 (7): 973–981. doi:10.1172/JCI15912. PMC 151149.
  21. ^ a b c Bole-Feysot, C; Goffin, V; Edery, M; Binart, N; Kelly, PA (1998). "Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice". Endocrine Reviews. 19 (3): 225–268. doi:10.1210/edrv.19.3.0334. PMID 9626554.
  22. ^ Brown, RSE; et al. (2019). "Acute suppression of LH secretion by prolactin in female mice is mediated by kisspeptin neurons in the arcuate nucleus". Endocrinology. 160 (5): 1323–1332. doi:10.1210/en.2019-00038. PMID 30901026.
  23. ^ Manzon, LA (2002). "The role of prolactin in fish osmoregulation: a review". General and Comparative Endocrinology. 125 (2): 291–310. doi:10.1006/gcen.2001.7746. PMID 11884075.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.